Annual Cash & Cash Equivalents
$1.28 B
+$491.68 M+62.55%
December 31, 2023
Summary
- As of March 12, 2025, LEGN annual cash & cash equivalents is $1.28 billion, with the most recent change of +$491.68 million (+62.55%) on December 31, 2023.
- During the last 3 years, LEGN annual cash & cash equivalents has risen by +$822.02 million (+180.39%).
- LEGN annual cash & cash equivalents is now at all-time high.
Performance
LEGN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$459.28 M
+$258.02 M+128.21%
September 30, 2024
Summary
- As of March 12, 2025, LEGN quarterly cash and cash equivalents is $459.28 million, with the most recent change of +$258.02 million (+128.21%) on September 30, 2024.
- Over the past year, LEGN quarterly cash and cash equivalents has dropped by -$818.44 million (-64.05%).
- LEGN quarterly cash and cash equivalents is now -64.05% below its all-time high of $1.28 billion, reached on December 31, 2023.
Performance
LEGN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
LEGN Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +62.5% | -64.0% |
| 3 y3 years | +180.4% | -64.0% |
| 5 y5 years | +507.9% | -64.0% |
LEGN Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +85.5% | -64.0% | +128.2% |
| 5 y | 5-year | at high | +1432.7% | -64.0% | +450.9% |
| alltime | all time | at high | +1432.7% | -64.0% | +450.9% |
Legend Biotech Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $459.28 M(+128.2%) |
| Jun 2024 | - | $201.25 M(-77.6%) |
| Mar 2024 | - | $897.57 M(-29.8%) |
| Dec 2023 | $1.28 B(+62.6%) | $1.28 B(+32.6%) |
| Sep 2023 | - | $963.47 M(-21.9%) |
| Jun 2023 | - | $1.23 B(+86.8%) |
| Mar 2023 | - | $660.05 M(-16.0%) |
| Dec 2022 | $786.03 M | $786.03 M(+107.0%) |
| Jun 2022 | - | $379.78 M(+0.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $377.79 M(-45.2%) |
| Dec 2021 | $688.94 M(+51.2%) | $688.94 M(+103.6%) |
| Sep 2021 | - | $338.33 M(-17.9%) |
| Mar 2021 | - | $412.30 M(-9.5%) |
| Dec 2020 | $455.69 M(+446.6%) | $455.69 M(+1.4%) |
| Sep 2020 | - | $449.38 M(-20.1%) |
| Jun 2020 | - | $562.39 M(+233.2%) |
| Mar 2020 | - | $168.80 M(+102.5%) |
| Dec 2019 | $83.36 M(-60.3%) | $83.36 M |
| Dec 2018 | $210.17 M | - |
FAQ
- What is Legend Biotech annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for Legend Biotech?
- What is Legend Biotech annual cash & cash equivalents year-on-year change?
- What is Legend Biotech quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for Legend Biotech?
- What is Legend Biotech quarterly cash and cash equivalents year-on-year change?
What is Legend Biotech annual cash & cash equivalents?
The current annual cash & cash equivalents of LEGN is $1.28 B
What is the all time high annual cash & cash equivalents for Legend Biotech?
Legend Biotech all-time high annual cash & cash equivalents is $1.28 B
What is Legend Biotech annual cash & cash equivalents year-on-year change?
Over the past year, LEGN annual cash & cash equivalents has changed by +$491.68 M (+62.55%)
What is Legend Biotech quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of LEGN is $459.28 M
What is the all time high quarterly cash and cash equivalents for Legend Biotech?
Legend Biotech all-time high quarterly cash and cash equivalents is $1.28 B
What is Legend Biotech quarterly cash and cash equivalents year-on-year change?
Over the past year, LEGN quarterly cash and cash equivalents has changed by -$818.44 M (-64.05%)